ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $113,000 | +52.7% | 2,169 | +38.6% | 0.00% | +33.3% |
| Q2 2022 | $74,000 | +21.3% | 1,565 | +83.7% | 0.00% | +50.0% |
| Q1 2022 | $61,000 | -46.5% | 852 | -44.3% | 0.00% | -50.0% |
| Q4 2021 | $114,000 | +395.7% | 1,529 | +224.6% | 0.00% | +300.0% |
| Q1 2021 | $23,000 | -41.0% | 471 | -44.8% | 0.00% | -75.0% |
| Q3 2020 | $39,000 | -17.0% | 853 | -8.6% | 0.00% | -20.0% |
| Q2 2020 | $47,000 | +261.5% | 933 | +522.0% | 0.01% | +25.0% |
| Q2 2019 | $13,000 | +1200.0% | 150 | +1566.7% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 9 | -55.0% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |